GREENLAND MINES LTD Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GREENLAND MINES LTD stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.40M.
- GREENLAND MINES LTD stock issued during period, value, new issues for the quarter ending 2025-09-30 was $5.30K.
- GREENLAND MINES LTD stock issued during period, value, new issues for the quarter ending 2022-03-31 was $25.00K.
- GREENLAND MINES LTD stock issued during period, value, new issues for fiscal 2025 was $1.11M.
- GREENLAND MINES LTD stock issued during period, value, new issues for fiscal 2022 was $25.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $2.40M 10-Q · filed 2026-08-17 | |
| 2025-12-31 | $1.11M 10-K/A · filed 2026-08-14 | |
| 2025-09-30 | $5.30K 10-Q · filed 2025-11-13 | |
| 2022-12-31 | $25.00K 10-K · filed 2024-04-17 | |
| 2022-03-31 | $25.00K 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |